The objective is to develop an original and non-invasive therapeutic medical device for children with ADHD. Developed in close collaboration with neuroscientists and clinicians, the personalized medical solution
Under the double-blind, placebo-controlled, parallel-group study, about 120 patients will be randomized to receive once-daily VK5211 doses of 0.5 mg, 1.0 mg or 2.0 mg or placebo for
Assistant Professor of Marketing Jesse Catlin led the study, "Dangerous Double Dosing: How Naive Beliefs Can Contribute to Unintentional Overdose with Over-the-Counter Drugs," which will be published this
The acquisition was completed by means of a short-form merger under the Delaware law. Post the short-form merger, InSite Vision has become an indirect wholly-owned subsidiary of Sun
The companies will develop joint protocols that explore potential synergistic effects of their respective drug candidates, as well as potential new drug candidate opportunities. "After recent discussions with
The Conception Kit at-home system contains a comprehensive collection of materials including 24 ovulation predictors, three pregnancy tests, and the innovative Conception Cap. Patients who purchased the same
In Switzerland, the classification of "transplant products" includes cell therapies such as Apligraf. With marketing approval of Apligraf, Switzerland has become the first country in Europe to grant
TruSkin has been developed to provide healthcare professionals a new option for treating large, chronic wounds in the Hospital Outpatient, Private Office, and/or Surgical Settings, where allograft options
The recall is specific to the Allerject epinephrine auto-injector, manufactured by Sanofi and does not apply to EpiPen. Pfizer Canada has already shipped its current EpiPen inventory to
Alexza and Teva also plan to restructure the obligations under the outstanding note from Teva. Alexza and Teva are working on a transition agreement to continue product availability
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.